- Fraudulent Email Warning（27KB）
News Release
- April 3, 2026
- Notice of Personnel Changes（73KB）
- April 1, 2026
- Instruction for New Employees from President Yamazaki at Induction Ceremony 2026（346KB）
- March 25, 2026
- Announcement of Investment by Development Bank of Japan Inc. in a U.S. Subsidiary of NIPRO（324KB）
IR News
- March 26, 2026
- CFO ｢Overview of Today’s Presentation｣ / Global Business Division ｢Overseas Business Strategy and Product Strategy｣ / Vascular Business Division ｢Global Product Strategy｣ / Value Engineering Management ｢Initiatives for Lean and Resilient Management｣
- February 9, 2026
- Consolidated Financial Results for the Nine Months Ended December 31, 2025 [Japanese GAAP] / Notice Regarding Recording of Extraordinary Income (Gain on Step Acquisition) / IR Materials
- December 9, 2025
- The 73rd Interim Shareholders’ Newsletter
Our Business
Meeting the needs of front line medical treatment with unique products and technologies
To meet the needs of the front line of medical treatment, NIPRO creates unique products at its four research and development sites while leveraging the technologies cultivated in its various businesses.
Mission, Vision, Value
We will work as a truly global comprehensive medical manufacturer with a willingness to consider patient and user viewpoints.
